Tyrosine kinase inhibitors inhibit glucose-stimulated insulin secretion.
Jones
P M
PM
Biomedical Sciences Division, King's College London, Kensington, U.K.
Persaud
S J
SJ
D000818:Animals; D002396:Catechols / Q000494:pharmacology; D019833:Genistein; D005947:Glucose / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D007329:Insulin Antagonists / Q000494:pharmacology*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D007529:Isoflavones / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D010766:Phosphorylation; D019000:Phosphotyrosine; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051381:Rats; D014443:Tyrosine / Q000031:analogs & derivatives / Q000276:immunology; D020032:Tyrphostins
D002396:Catechols; D007328:Insulin; D007329:Insulin Antagonists; D007529:Isoflavones; D009570:Nitriles; D020032:Tyrphostins; C060152:tyrphostin 47; D019000:Phosphotyrosine; D014443:Tyrosine; D019833:Genistein; D011505:Protein-Tyrosine Kinases; D005947:Glucose